AP-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AP-101, covering 2025-08-19 to 2025-08-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]